VOYA Investment Management
TXG icon

VOYA Investment Management’s 10x Genomics TXG Stock Holding History

VOYA Investment Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Buy
122,915
+9,570
+8% +$251K ﹤0.01% 888
2026
Q1 		$2.41M Buy
113,345
+78,103
+222% +$1.56M ﹤0.01% 1103
2025
Q4 		$575K Sell
35,242
-2,430
-6% -$36.7K ﹤0.01% 1683
2025
Q3 		$440K Sell
37,672
-10,692
-22% -$139K ﹤0.01% 1815
2025
Q2 		$560K Sell
48,364
-47,060
-49% -$429K ﹤0.01% 1840
2025
Q1 		$833K Buy
95,424
+18,635
+24% +$235K ﹤0.01% 1645
2024
Q4 		$1.1M Buy
76,789
+4,943
+7% +$78K ﹤0.01% 1543
2024
Q3 		$1.62M Sell
71,846
-6,004
-8% -$124K ﹤0.01% 1411
2024
Q2 		$1.51M Sell
77,850
-336,395
-81% -$8.81M ﹤0.01% 1416
2024
Q1 		$15.5M Buy
414,245
+353,687
+584% +$15.5M 0.02% 616
2023
Q4 		$3.39M Buy
60,558
+19,250
+47% +$838K ﹤0.01% 1150
2023
Q3 		$1.7M Sell
41,308
-1,355
-3% -$70.5K ﹤0.01% 1394
2023
Q2 		$2.38M Buy
42,663
+8,235
+24% +$446K ﹤0.01% 1285
2023
Q1 		$1.92M Sell
34,428
-985
-3% -$46K ﹤0.01% 1370
2022
Q4 		$1.29M Buy
35,413
+3
+0% +$98 ﹤0.01% 1522
2022
Q3 		$1.01M Sell
35,410
-394
-1% -$15K ﹤0.01% 1627
2022
Q2 		$1.62M Sell
35,804
-5,298
-13% -$275K ﹤0.01% 1194
2022
Q1 		$3.13M Sell
41,102
-4,370
-10% -$382K 0.01% 979
2021
Q4 		$6.77M Buy
45,472
+17,062
+60% +$2.61M 0.01% 735
2021
Q3 		$4.14M Sell
28,410
-60,198
-68% -$10.3M 0.01% 909
2021
Q2 		$17.4M Buy
88,608
+7,904
+10% +$1.43M 0.03% 396
2021
Q1 		$14.6M Buy
80,704
+58,412
+262% +$10.1M 0.03% 443
2020
Q4 		$3.16M Buy
22,292
+991
+5% +$144K 0.01% 966
2020
Q3 		$2.66M Buy
21,301
+308
+1% +$32.3K 0.01% 931
2020
Q2 		$1.88M Buy
+20,993
New +$1.64M ﹤0.01% 1043

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VOYA Investment Management's TXG Position: Q2 2026 in Review

VOYA Investment Management increased its 10x Genomics (TXG) stake by 8.4% in Q2 2026, buying an estimated $251K and bringing the position to 122,915 shares worth $4.71M. The position accounts for ﹤0.01% of the portfolio, ranked #888.

VOYA Investment Management first reported a position in TXG in Q2 2020 and has held it in 25 quarters since. The position peaked at $17.4M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • VOYA Investment Management held 122,915 shares of 10x Genomics worth $4.71M as of Q2 2026.
  • VOYA Investment Management bought 9,570 10x Genomics shares in Q2 2026, an estimated $251K.
  • 10x Genomics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #888 holding.
  • VOYA Investment Management first reported a position in 10x Genomics in Q2 2020 and has held it in 25 quarters since.
  • VOYA Investment Management's 10x Genomics position peaked at $17.4M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.